CORDIS
EU research results

CORDIS

English EN
Healthcare- and pharma-economic models in support of the International Consortium for Personalised Medicine

Healthcare- and pharma-economic models in support of the International Consortium for Personalised Medicine

Objective

HEcoPerMed responds to the demand for economic models that evaluate treatments made possible through innovations in personalised medicine and seeks to identify funding and reimbursement mechanisms that provide financial incentives for the rapid development and uptake of such innovations. HEcoPerMed goes beyond current assessment and payment models in order to serve the requirements of personalised medicine for more compre-hensive cost-effectiveness estimates that incorporate patient and societal perspectives and enhance sustainable affordability of cutting-edge health innovations. HEcoPerMed will provide an overview of and guidance on high-quality methodological approaches for model-based economic evaluations. In three case studies, HEcoPerMedwill apply state-of-the art economic modelling to demonstrate practical and methodological issues in evaluating personalised medicine innovations. The project team will also study existing shortcomings in stimulating the adoption of personalised medicine and pro-pose financial agreements that accelerate its diffusion in European health systems. HEcoPerMed will construct future scenarios, considering the trends and drivers as well as challenges and benefits of personalised medicine for the European social model of care and its financial viability. For a better financial integration of personalised medicine and new economic models, the project team will develop appropriate diffusion and communication strategies to be in direct contact with experts and a wide variety of stakeholders, taking their needs into account while offering new solutions for the players within the European health systems. These comprehensive measures will fill a gap identified by the ICPerMed to support their efforts in the promotion of personalised medicine in Europe and beyond. The project will support health care decision makers to manage their budgets while providing the best possible care for patients in the field of personalised medicine.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH

Address

Giefinggasse 4
1210 Wien

Austria

Activity type

Research Organisations

EU Contribution

€ 312 500

Participants (4)

Sort alphabetically

Sort by EU Contribution

Expand all

DEUTSCHES ZENTRUM FUER LUFT - UND RAUMFAHRT EV

Germany

EU Contribution

€ 700 937,50

INSTITUTE FOR MEDICAL TECHNOLOGY ASSESSMENT BV

Netherlands

EU Contribution

€ 376 250

SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG

Hungary

EU Contribution

€ 225 000

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

United Kingdom

EU Contribution

€ 383 750

Project information

Grant agreement ID: 824997

Status

Ongoing project

  • Start date

    1 January 2019

  • End date

    31 December 2021

Funded under:

H2020-EU.3.1.6.

  • Overall budget:

    € 1 998 437,50

  • EU contribution

    € 1 998 437,50

Coordinated by:

AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH

Austria